Biohaven Pharmaceutical Holding Stock Price History

BHVN Stock  USD 44.03  0.26  0.59%   
If you're considering investing in Biohaven Stock, it is important to understand the factors that can impact its price. As of today, the current price of Biohaven Pharmaceutical stands at 44.03, as last reported on the 18th of April 2024, with the highest price reaching 45.60 and the lowest price hitting 42.55 during the day. We consider Biohaven Pharmaceutical not too volatile. Biohaven Pharmaceutical secures Sharpe Ratio (or Efficiency) of 0.0167, which signifies that the company had a 0.0167% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Biohaven Pharmaceutical Holding, which you can use to evaluate the volatility of the firm. Please confirm Biohaven Pharmaceutical's Mean Deviation of 2.58, risk adjusted performance of 0.0134, and Downside Deviation of 3.94 to double-check if the risk estimate we provide is consistent with the expected return of 0.0657%.
  
At this time, Biohaven Pharmaceutical's Total Stockholder Equity is very stable compared to the past year. As of the 18th of April 2024, Other Stockholder Equity is likely to grow to about 73.8 M, while Liabilities And Stockholders Equity is likely to drop about 347.2 M. . At this time, Biohaven Pharmaceutical's Price Book Value Ratio is very stable compared to the past year. As of the 18th of April 2024, Price Earnings To Growth Ratio is likely to grow to 0.14, while Price To Sales Ratio is likely to drop 8.54. Biohaven Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0167

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskBHVNHuge Risk
Negative Returns

Estimated Market Risk

 3.94
  actual daily
34
66% of assets are more volatile

Expected Return

 0.07
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.02
  actual daily
1
99% of assets perform better
Based on monthly moving average Biohaven Pharmaceutical is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biohaven Pharmaceutical by adding it to a well-diversified portfolio.
Price Book
10.1281
Book Value
5.276
Enterprise Value
3.2 B
Enterprise Value Ebitda
(9.28)
Shares Float
65.9 M

Biohaven Pharmaceutical Stock Price History Chart

There are several ways to analyze Biohaven Stock price data. The simplest method is using a basic Biohaven candlestick price chart, which shows Biohaven Pharmaceutical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMarch 13, 202459.75
Lowest PriceApril 16, 202443.77

Biohaven Pharmaceutical April 18, 2024 Stock Price Synopsis

Various analyses of Biohaven Pharmaceutical's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Biohaven Stock. It can be used to describe the percentage change in the price of Biohaven Pharmaceutical from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Biohaven Stock.
Biohaven Pharmaceutical Price Action Indicator 0.09 
Biohaven Pharmaceutical Price Daily Balance Of Power 0.09 
Biohaven Pharmaceutical Price Rate Of Daily Change 1.01 

Biohaven Pharmaceutical April 18, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Biohaven Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Biohaven Pharmaceutical intraday prices and daily technical indicators to check the level of noise trading in Biohaven Stock and then apply it to test your longer-term investment strategies against Biohaven.

Biohaven Stock Price History Data

The price series of Biohaven Pharmaceutical for the period between Fri, Jan 19, 2024 and Thu, Apr 18, 2024 has a statistical range of 17.04 with a coefficient of variation of 10.01. The prices are distributed with arithmetic mean of 50.31. The median price for the last 90 days is 48.71.
OpenHighLowCloseVolume
04/18/2024
 44.14  45.60  42.55  44.03 
04/17/2024 44.14  45.60  42.55  44.03  1,040,176 
04/16/2024 44.77  45.07  42.35  43.77  1,955,033 
04/15/2024 50.96  52.50  43.58  44.77  3,401,934 
04/12/2024 53.49  53.70  52.13  53.08  792,385 
04/11/2024 51.53  53.80  51.20  53.49  697,997 
04/10/2024 50.37  51.60  49.77  51.06  718,485 
04/09/2024 51.62  53.13  50.85  51.98  756,411 
04/08/2024 52.29  52.42  50.02  51.41  834,721 
04/05/2024 51.93  53.73  51.36  52.52  584,172 
04/04/2024 52.70  55.72  51.60  52.33  879,794 
04/03/2024 50.25  52.74  50.25  52.28  934,423 
04/02/2024 50.99  52.15  50.10  50.79  1,230,465 
04/01/2024 54.69  54.69  51.57  52.06  936,067 
03/28/2024 57.02  57.02  54.65  54.69  841,480 
03/27/2024 56.88  57.07  54.22  57.02  834,506 
03/26/2024 58.20  59.53  56.20  56.29  1,815,133 
03/25/2024 55.62  56.32  55.13  55.23  1,190,764 
03/22/2024 55.63  56.43  55.25  55.85  1,011,526 
03/21/2024 60.17  60.46  55.85  55.88  1,791,806 
03/20/2024 56.02  59.37  55.43  59.36  921,317 
03/19/2024 56.01  57.83  55.45  56.95  2,448,834 
03/18/2024 58.26  58.97  56.26  56.74  1,935,701 
03/15/2024 55.32  57.95  54.95  57.07  3,605,921 
03/14/2024 58.98  59.15  55.44  56.42  2,052,851 
03/13/2024 58.30  60.83  58.01  59.75  2,362,404 
03/12/2024 54.58  58.70  54.40  58.58  1,274,765 
03/11/2024 57.56  57.99  54.00  55.38  1,499,873 
03/08/2024 59.00  62.21  55.88  57.97  1,700,918 
03/07/2024 58.99  59.25  56.58  58.05  1,288,304 
03/06/2024 59.60  60.22  56.80  58.13  1,209,661 
03/05/2024 56.05  61.25  56.01  58.65  2,011,712 
03/04/2024 51.50  58.83  51.15  56.39  2,579,407 
03/01/2024 47.48  51.78  46.25  49.54  1,741,747 
02/29/2024 48.56  49.38  46.83  48.14  1,550,442 
02/28/2024 47.20  48.04  46.26  47.30  824,661 
02/27/2024 46.96  48.58  45.85  47.66  1,065,534 
02/26/2024 47.20  48.00  44.39  46.18  1,210,477 
02/23/2024 48.38  49.61  47.25  47.31  686,976 
02/22/2024 47.00  48.50  46.86  47.33  532,640 
02/21/2024 46.85  47.70  45.20  46.57  829,451 
02/20/2024 48.92  50.68  46.98  47.24  1,097,590 
02/16/2024 48.86  50.22  48.44  49.50  667,098 
02/15/2024 47.57  49.25  47.57  49.11  628,770 
02/14/2024 48.00  48.92  45.69  47.12  800,681 
02/13/2024 46.90  48.26  46.05  46.95  1,324,235 
02/12/2024 49.28  50.23  47.97  48.71  695,219 
02/09/2024 47.12  48.93  47.12  48.55  508,927 
02/08/2024 47.26  48.20  46.18  46.92  641,580 
02/07/2024 47.27  48.21  46.93  47.26  517,616 
02/06/2024 47.77  48.58  46.57  47.21  865,787 
02/05/2024 44.79  47.50  44.26  47.16  948,445 
02/02/2024 44.06  45.07  43.05  44.79  680,728 
02/01/2024 44.92  45.74  43.94  45.00  576,121 
01/31/2024 43.89  46.37  43.89  44.48  913,931 
01/30/2024 45.25  45.90  43.65  43.81  991,242 
01/29/2024 45.50  46.61  44.90  45.67  807,489 
01/26/2024 45.10  45.30  44.19  44.89  508,742 
01/25/2024 46.09  47.23  44.90  44.97  757,868 
01/24/2024 49.10  49.58  45.33  45.60  599,827 
01/23/2024 49.03  49.65  46.88  48.31  1,175,653 

About Biohaven Pharmaceutical Stock history

Biohaven Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biohaven is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biohaven Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biohaven Pharmaceutical stock prices may prove useful in developing a viable investing in Biohaven Pharmaceutical
Last ReportedProjected for Next Year
Common Stock Shares Outstanding71.2 M51.9 M
Net Loss-513.3 M-538.9 M

Biohaven Pharmaceutical Quarterly Net Working Capital

387.02 Million

Biohaven Pharmaceutical Stock Technical Analysis

Biohaven Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Biohaven Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Biohaven Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Biohaven Pharmaceutical Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Biohaven Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Biohaven Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biohaven to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Biohaven Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biohaven Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biohaven Pharmaceutical Holding Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biohaven Pharmaceutical Holding Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Biohaven Stock analysis

When running Biohaven Pharmaceutical's price analysis, check to measure Biohaven Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biohaven Pharmaceutical is operating at the current time. Most of Biohaven Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Biohaven Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biohaven Pharmaceutical's price. Additionally, you may evaluate how the addition of Biohaven Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Is Biohaven Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.73)
Return On Assets
(0.46)
Return On Equity
(0.84)
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.